DEERFIELD, Ill. & CAMP HILL, Pa.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) and Rite Aid Corporation
(NYSE: RAD) today announced that, in accordance with the terms of their
merger agreement dated 27 October 2015, they have mutually agreed to
extend the end date of their merger agreement from 27 October 2016 to 27
January 2017. The companies now expect the transaction will close in
early calendar 2017.
On 27 October 2015, the companies entered into a definitive agreement
under which Walgreens Boots Alliance agreed to acquire all outstanding
shares of Rite Aid for $9.00 per share in cash. Under the terms of the
merger agreement, either party has the right to extend the end date from
27 October 2016 to 27 January 2017 by delivery of notice to the other.
Notes to Editors:
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led,
health and wellbeing enterprise.
The company was created through the combination of Walgreens and
Alliance Boots in December 2014, bringing together two leading companies
with iconic brands, complementary geographic footprints, shared values
and a heritage of trusted health care services through pharmaceutical
wholesaling and community pharmacy care, dating back more than 100 years.
Walgreens Boots Alliance is the largest retail pharmacy, health and
daily living destination across the USA and Europe. Walgreens Boots
Alliance and the companies in which it has equity method investments
together have a presence in more than 25* countries and employ more than
400,000* people. The company is a global leader in pharmacy-led, health
and wellbeing retail and, together with the companies in which it has
equity method investments, has over 13,200* stores in 11* countries as
well as one of the largest global pharmaceutical wholesale and
distribution networks, with over 390* distribution centers delivering to
more than 230,000** pharmacies, doctors, health centers and hospitals
each year in more than 20* countries. In addition, Walgreens Boots
Alliance is one of the world’s largest purchasers of prescription drugs
and many other health and wellbeing products.
The company’s portfolio of retail and business brands includes
Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as
increasingly global health and beauty product brands, such as No7,
Botanics, Liz Earle and Soap & Glory. More company information is
available at www.walgreensbootsalliance.com.
* As of 31 August 2016, using publicly available information for
** For 12 months ending 31 August 2016, using publicly available
information for AmerisourceBergen.
About Rite Aid
Rite Aid Corporation (NYSE: RAD) is one of the nation’s leading
drugstore chains with nearly 4,600 stores in 31 states and the District
of Columbia and fiscal 2016 annual revenues of $30.7 billion.
Information about Rite Aid, including corporate background and press
releases, is available through the company’s website at www.riteaid.com.
Cautionary Note Regarding Forward-Looking Statements: All statements
in this release that are not historical statements, which include,
without limitation, those regarding the pending merger agreement between
Walgreens Boots Alliance, Inc. and Rite Aid Corporation and the
transactions contemplated thereby and their possible timing and effects,
are forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Words such as “expect,” “pending,” “potential”, “likely,” “preliminary,”
“would,” “could,” “should,” “can,” “will,” “project,” “intend,” “plan,”
“goal,” “continue,” “synergy,” “on track,” “believe,” “seek,”
“estimate,” “anticipate,” “may,” “possible,” “assume,” and variations of
such words and similar expressions are intended to identify such
forward-looking statements. These forward-looking statements are not
guarantees of future performance and are subject to risks, uncertainties
and assumptions, known or unknown, which could cause actual results to
vary materially from those indicated or anticipated. These include, but
are not limited to, the outcome of legal and regulatory matters,
including with respect to the outcome of discussions with the Federal
Trade Commission and otherwise in connection with the pending
acquisition of Rite Aid by Walgreens Boots Alliance; the number of
stores divested in connection with such pending acquisition and the
terms, timing and consummation of such transactions; the risk of
unexpected costs, liabilities or delays, changes in management’s
assumptions, risks associated with acquisitions, including those
relating to the ability to satisfy the closing conditions and consummate
the pending acquisition of Rite Aid by Walgreens Boots Alliance and
related matters on a timely basis or at all; the risks associated with
the integration of complex businesses; and the other risks and
uncertainties described in the reports that Walgreens Boots Alliance and
Rite Aid have filed with the Securities and Exchange Commission (“SEC”).
A further list and description of risks and uncertainties can be found
in Item 1A (Risk Factors) in Walgreens Boots Alliance’s Annual Report on
Form 10-K for the fiscal year ending 31 August 2015 and its subsequent
reports on Form 10-Q as well as Rite Aid’s Annual Report on Form 10-K
for the fiscal year ending 27 February 2016 and its subsequent reports
on Form 10-Q. Should one or more of these risks or uncertainties
materialize, or should underlying assumptions prove incorrect, actual
results may vary materially from those indicated or anticipated by such
forward-looking statements. Accordingly, you are cautioned not to place
undue reliance on these forward-looking statements, which speak only as
of the date they are made. Walgreens Boots Alliance and Rite Aid
expressly disclaim any current intention to update publicly any
forward-looking statement after the distribution of this release,
whether as a result of new information, future events, changes in
assumptions or otherwise.
Walgreens Boots Alliance, Inc.
/ Michael Polzin, +1 847 315 2935
International / Laura Vergani,
+44 (0)207 980 8585
Gradwell and Ashish Kohli, +1 847 315 2922
Ashley Flower, +1 717
Matt Schroeder, +1
717 214 8867